Stock CONTEXT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Comparison Chart Context Therapeutics Inc.

Equities

US21077P1084

Real-time Estimate Cboe BZX
Other stock markets
 12:50:45 21/06/2024 am IST 		5-day change 1st Jan Change
1.935 USD -85.12% Intraday chart for Context Therapeutics Inc. 0.00% 0.00%
08/05 Context Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
06/05 Context Therapeutics Inc. announced that it has received $99.992767 million in funding from Ally Bridge Group, Avidity Partners, LLC, Blue Owl Healthcare Opportunities, Deep Track Capital, LP, Driehaus Capital Management LLC, Great Point Partners, LLC CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. Stock
  4. Charts Context Therapeutics Inc.
  5. Comparison Chart